322 related articles for article (PubMed ID: 27543771)
1. Survival in the pre-senile dementia frontotemporal lobar degeneration with TDP-43 proteinopathy: effects of genetic, demographic and neuropathological variables.
Armstrong RA
Folia Neuropathol; 2016; 54(2):137-48. PubMed ID: 27543771
[TBL] [Abstract][Full Text] [Related]
2. Cortical degeneration in frontotemporal lobar degeneration with TDP-43 proteinopathy caused by progranulin gene mutation.
Armstrong RA
Int J Neurosci; 2014 Dec; 124(12):894-903. PubMed ID: 24494724
[TBL] [Abstract][Full Text] [Related]
3. Laminar distribution of the pathological changes in sporadic frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy: a quantitative study using polynomial curve fitting.
Armstrong RA; Hamilton RL; Mackenzie IR; Hedreen J; Cairns NJ
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):335-47. PubMed ID: 22804696
[TBL] [Abstract][Full Text] [Related]
4. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.
Armstrong RA; Ellis W; Hamilton RL; Mackenzie IR; Hedreen J; Gearing M; Montine T; Vonsattel JP; Head E; Lieberman AP; Cairns NJ
J Neural Transm (Vienna); 2010 Feb; 117(2):227-39. PubMed ID: 20012109
[TBL] [Abstract][Full Text] [Related]
5. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.
Armstrong RA; Cairns NJ
Histol Histopathol; 2011 Feb; 26(2):185-90. PubMed ID: 21154232
[TBL] [Abstract][Full Text] [Related]
6. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
Armstrong RA; Carter D; Cairns NJ
Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
[TBL] [Abstract][Full Text] [Related]
7. Spatial patterns of TDP-43 neuronal cytoplasmic inclusions (NCI) in fifteen cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
Armstrong RA; Cairns NJ
Neurol Sci; 2011 Aug; 32(4):653-9. PubMed ID: 21647631
[TBL] [Abstract][Full Text] [Related]
8. Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy.
Thorpe JR; Tang H; Atherton J; Cairns NJ
J Neural Transm (Vienna); 2008 Dec; 115(12):1661-71. PubMed ID: 18974920
[TBL] [Abstract][Full Text] [Related]
9. [FTLD/ALS as TDP-43 proteinopathies].
Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
[TBL] [Abstract][Full Text] [Related]
10. Old age genetically confirmed frontotemporal lobar degeneration with TDP-43 has limbic predominant TDP-43 deposition.
Buciuc M; Whitwell JL; Baker MC; Rademakers R; Dickson DW; Josephs KA
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1050-1059. PubMed ID: 33969528
[TBL] [Abstract][Full Text] [Related]
11. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathological spectrum of TDP-43 associated ALS].
Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
[TBL] [Abstract][Full Text] [Related]
13. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.
Kawakami I; Arai T; Hasegawa M
Acta Neuropathol; 2019 Nov; 138(5):751-770. PubMed ID: 31555895
[TBL] [Abstract][Full Text] [Related]
14. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
[TBL] [Abstract][Full Text] [Related]
15. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions.
Mackenzie IR; Foti D; Woulfe J; Hurwitz TA
Brain; 2008 May; 131(Pt 5):1282-93. PubMed ID: 18362096
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database.
Woodworth DC; Nguyen KM; Sordo L; Scambray KA; Head E; Kawas CH; Corrada MM; Nelson PT; Sajjadi SA
Acta Neuropathol; 2024 Jun; 147(1):103. PubMed ID: 38896163
[TBL] [Abstract][Full Text] [Related]
17. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O
Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879
[TBL] [Abstract][Full Text] [Related]
18. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease.
Brandmeir NJ; Geser F; Kwong LK; Zimmerman E; Qian J; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):123-31. PubMed ID: 18004574
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss.
Kobayashi Z; Tsuchiya K; Arai T; Yokota O; Yoshida M; Shimomura Y; Kondo H; Haga C; Asaoka T; Onaya M; Ishizu H; Akiyama H; Mizusawa H
J Neurol Sci; 2010 Nov; 298(1-2):70-7. PubMed ID: 20810131
[TBL] [Abstract][Full Text] [Related]
20. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.
Lashley T; Rohrer JD; Bandopadhyay R; Fry C; Ahmed Z; Isaacs AM; Brelstaff JH; Borroni B; Warren JD; Troakes C; King A; Al-Saraj S; Newcombe J; Quinn N; Ostergaard K; Schrøder HD; Bojsen-Møller M; Braendgaard H; Fox NC; Rossor MN; Lees AJ; Holton JL; Revesz T
Brain; 2011 Sep; 134(Pt 9):2548-64. PubMed ID: 21752791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
